Drug Information

Drug General Information
Drug ID
D0D6SZ
Former ID
DIB004613
Drug Name
TROXACITABINE
Synonyms
Troxatyl; BCH-4556; SPD-758; Troxacitabine < Prop INN; Beta-L-OddC; (-)-beta-L-Dioxolanecytidine
Drug Type
Small molecular drug
Indication Solid tumours [ICD9: 140-199, 210-229; ICD10:C00-D48] Phase 2 [521659]
Company
Shire Pharmaceuticals
Structure
Download
2D MOL

3D MOL
Formula
C8H11N3O4
Canonical SMILES
NC1=NC(=O)N(C=C1)[C@@H]2CO[C@H](CO)O2
InChI
1S/C8H11N3O4/c9-5-1-2-11(8(13)10-5)6-4-14-7(3-12)15-6/h1-2,6-7,12H,3-4H2,(H2,9,10,13)/t6-,7-/m0/s1
InChIKey
RXRGZNYSEHTMHC-BQBZGAKWSA-N
PubChem Compound ID
151173
Target and Pathway
Target(s) Human DNA Target Info Binder [527096]
References
Ref 521659ClinicalTrials.gov (NCT00129948) Study for Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML). U.S. National Institutes of Health.
Ref 527096Troxacitabine. Bull Cancer. 2004 Mar;91(3):213-8.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.